0 Items
Select Page

Salmonella

Typhoid fever and paratyphoid fever are life-threatening illnesses caused by Salmonella typhi and paratyphi, respectively. Most people in Western countries who contract typhoid fever or paratyphoid fever become infected while traveling abroad, most often to countries where these diseases are common.

The Native Antigen Company offers monoclonal antibodies that can distinguish between Salmonella typhi and paratyphi diseases.

Salmonella Background

The bacterial genus, Salmonella are rod-shaped, gram-negative, facultative anaerobic bacilli, that belong to the family Enterobacteriaceae. The genus is divided into two species groups, Salmonella enterica and Salmonella bongoriS. enterica is further divided into six subspecies which includes S. enterica subspecies entericaSalmonella typhi is a serovar of this subspecies and is classified as Salmonella enterica serovar typhi. Both S. typhi and S. paratyphi belong to the same subspecies and are generally referred to as Salmonella.

Infection caused by S. typhi or S. paratyphi is generally referred to as typhoid fever. The symptoms caused by S. paratyphi infection are milder than disease caused by S. typhi and include fever, headaches, nausea, loss of appetite, constipation and diarrhoea. In a small percentage of cases, infected individuals may become chronic carriers of S. paratyphi or S. typhi after infection and are responsible for spreading the disease in endemic regions.

Humans are the sole reservoir for S. paratyphi, and the bacterium is transmitted from one person to another through water or food, that has been contaminated with the faeces of an infected individual. S. paratyphi infection is common in developing countries, particularly in densely populated urban areas with poor sanitation and lack of safe drinking water. S. paratyphi primarily invades the gastrointestinal tract and replicates within non-phagocytic epithelial cells and phagocytic cells, thereby evading the immune system (Hurley, D).

Three S. paratyphi serotypes cause paratyphoid fever, which are classified as A, B and C. Paratyphoid fever is symptomatically indistinguishable from typhoid fever, which is caused by S. typhi, and both diseases are referred to as enteric fever. The symptoms of paratyphoid fever are milder than typhoid fever and include fever, headaches, nausea, loss of appetite, constipation, diarrhoea. In a small percentage of cases, infected individuals may become chronic carriers of S. paratyphi after infection, and are responsible for spreading the disease in endemic regions.

Paratyphoid fever, caused by Salmonella enterica serovar paratyphi remains an important public health burden in developing countries and affects travellers visiting countries where S. paratyphi is endemic. Vaccines are not currently available to protect individuals against paratyphoid fever, but licensed vaccines for typhoid fever may provide limited protection (WHO).

References

  1. Hurley D, McCusker MP, Fanning S, Martins M. (2014). Salmonella-host interactions – modulation of the host innate immune system. Front Immunol. Oct 7;5:481.
  1. World health organization: Typhoid

Salmonella Antibodies

We offer two monoclonal antibodies specific to Salmonella spp., one which is specific for S. typhi and one specific to S. paratyphi.

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Diagnosing HIV in resource-limited settings

In this blog, we discuss the need for improved point-of-care (PoC) diagnostics for HIV and present the virus's cellular mechanism to illustrate our new range of HIV antigens and antibodies. HIV in the developed world On June 5th 1981 in Los Angeles, California, 5...

Our Product Pipeline

If you’ve been following us on social media recently, you might have noticed that we’ve been releasing a lot of new antigens and antibodies. In this blog, we explain how we use the WHO R&D Blueprint to guide our product development and present some highlights from...

From Outbreak to Epidemic: A Short History of The Ebola Virus

In the first of a two-part series, we discuss the history of the Ebola virus up to the ongoing outbreak in the Democratic Republic of Congo, and why this disease has been so challenging to fight. The 2014/15 epidemic In the summer of 2014, the world watched as the...

ELISA Formats for Infectious Disease Diagnostics

The field of diagnostics is rapidly developing, yet ELISA and PCR methods remain the most commonly used techniques in the diagnosis of bacterial and viral infections. In this blog, we discuss the advantages of using serological methods over molecular, PCR-based...

The world’s most extensive range of NS1-specific antibodies for flavivirus research

The Native Antigen Company first gained prominence in 2016, when it developed highly pure Zika virus NS1 protein during the 2015/2016 epidemic. Since then, the company has developed an extensive range of highly specific antigens, antibodies and immunoassays for...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

13 + 10 =

Live Customer Feedback

Join our mailing list

* indicates required